Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lupus or SLE”

112 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 112 results

Early research (Phase 1)Looking for participantsNCT07361094
What this trial is testing

Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmune Diseases

Who this might be right for
Relapsed/Refractory Systemic Lupus ErythematosusRelapsed/Refractory Systemic SclerosisRelapsed/Refractory Idiopathic Inflammatory Myopathies+3 more
Beijing Boren Hospital 12
Testing effectiveness (Phase 2)Study completedNCT00391924
What this trial is testing

Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome

Who this might be right for
Lupus Erythematosus, SystemicSjogren's Syndrome
UMC Utrecht 120
Early research (Phase 1)Not Yet RecruitingNCT07306585
What this trial is testing

The Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subjects With SLE/CLE

Who this might be right for
Systemic Lupus Erythematosus (SLE)Cutaneous Lupus Erythematosus (CLE)
HC Biopharma Inc. 32
Large-scale testing (Phase 3)Not Yet RecruitingNCT07791199
What this trial is testing

Continued Access to Deucravacitinib for Adult SLE/SjD and Pediatric PsO/PsA Study Completers

Who this might be right for
Systemic Lupus ErythematosusSjögren's DiseasePsoriasis+1 more
Bristol-Myers Squibb 2,300
Testing effectiveness (Phase 2)WithdrawnNCT00230035
What this trial is testing

Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST)

Who this might be right for
Systemic Lupus Erythematosus
National Institute of Allergy and Infectious Diseases (NIAID)
Large-scale testing (Phase 3)UnknownNCT05686746
What this trial is testing

Use of Baricitenib to Maintain of Remission

Who this might be right for
Lupus or SLENephritis
Assiut University 80
Early research (Phase 1)Study completedNCT01894360
What this trial is testing

Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects

Who this might be right for
Systemic Lupus Erythematosus
GlaxoSmithKline 81
Post-approval studies (Phase 4)Looking for participantsNCT06875960
What this trial is testing

Continue the Administration of Deucravacitinib in Participants With Systemic Lupus Erythematosus (SLE) or Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE) Who Have Completed Study IM011074 or Study IM011132

Who this might be right for
Systemic Lupus Erythematosus (SLE)Discoid and/or Subacute Cutaneous Lupus Erythematosus (DLE/SCLE)
Bristol-Myers Squibb 35
Large-scale testing (Phase 3)WithdrawnNCT02074020
What this trial is testing

CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis

Who this might be right for
Systemic Lupus Erythematosus
Anthera Pharmaceuticals
Not applicableUnknownNCT05275348
What this trial is testing

Delivery of Enhance Fitness Trial

Who this might be right for
ArthritisRheumatoid ArthritisFibromyalgia+3 more
University of Washington 310
Testing effectiveness (Phase 2)Study completedNCT05162586
What this trial is testing

The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW)

Who this might be right for
Systemic Lupus Erythematosus
EMD Serono Research & Development Institute, Inc. 456
Not applicableStudy completedNCT00055055
What this trial is testing

Study of Families With Twins or Siblings Discordant for Rheumatic Disorders

Who this might be right for
Rheumatoid ArthritisSystemic Lupus ErythematosusIdiopathic Inflammatory Myopathies
National Institute of Environmental Health Sciences (NIEHS) 1,056
Very early researchLooking for participantsNCT06548607
What this trial is testing

Clinical Study on Targeted CD19 or CD19-BCMA CAR-T Therapy for Autoimmune Diseases

Who this might be right for
SLE (Systemic Lupus)Systemic SclerosisANCA Associated Vasculitis+3 more
Nanjing Bioheng Biotech Co., Ltd. 20
Large-scale testing (Phase 3)Study completedNCT04870333
What this trial is testing

PROphylaxis for paTiEnts at Risk of COVID-19 infecTion -V

Who this might be right for
Covid19
Cambridge University Hospitals NHS Foundation Trust 2,240
Testing effectiveness (Phase 2)UnknownNCT04835883
What this trial is testing

Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients

Who this might be right for
Systemic Lupus Erythematosus
Hanyang University Seoul Hospital 10
Not applicableEnrolling By InvitationNCT05859997
What this trial is testing

Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases

Who this might be right for
Systemic Lupus Erythematosus (SLE)Sjogren's SyndromeSystemic Sclerosis+3 more
Bioray Laboratories 15
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07782450
What this trial is testing

Learn About a Medicine Called PF-08154225 in Participants With Autoimmune Diseases

Who this might be right for
Systemic Lupus ErythematosusRheumatoid ArthritisIdiopathic Inflammatory Myositis+1 more
Pfizer 54
Early research (Phase 1)Looking for participantsNCT06676631
What this trial is testing

NK010 or NK042 in Combination With Rituximab for Refractory Systemic Lupus Erythematosus/Lupus Nephritis

Who this might be right for
Refractory Systemic Lupus ErythematosusRefractory Lupus Nephritis
Guangdong Provincial People's Hospital 18
Early research (Phase 1)Looking for participantsNCT06975787
What this trial is testing

Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis

Who this might be right for
Lupus Nephritis (LN)
Regeneron Pharmaceuticals 90
Testing effectiveness (Phase 2)Looking for participantsNCT07260877
What this trial is testing

A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus

Who this might be right for
Cutaneous Lupus Erythematosus (CLE)Systemic Lupus ErythematosusSLE+2 more
Ventus Therapeutics U.S., Inc. 24
Next Page